RECONNECT Study Evaluates Deep Brain Stimulation for Chronic Disorders of Consciousness
The RECONNECT study is assessing the safety and efficacy of deep brain stimulation in patients with chronic disorders of consciousness.
Phase III
Neurology / Deep Brain Stimulation
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
The RECONNECT study is pivotal as it explores innovative treatment options for chronic disorders of consciousness, potentially positioning the sponsor as a leader in neuromodulation. Success in this trial could significantly influence product development and partnerships in the neurology space.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor trial results and any subsequent publications or announcements regarding efficacy and safety outcomes.
Related companies & assets
Assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.